Uncategorized

Tornos, who took the helm in August, said the company will grow through internal innovation and M&A.

The CMS proposed a rule on Monday to stop brokers from steering beneficiaries to plans based on excessive compensation. It’s regulators’ latest move to curb Medicare Advantage marketing misconduct following a push from lawmakers.

Autobahn Therapeutics today announced positive topline results from a first-in-human Phase 1 clinical study assessing the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of escalating doses of ABX-002 in healthy volunteers.

BioSpace has published its annual 2024 Best Places to Work list.

As extreme weather events caused by climate change ramp up in frequency, hospitals are struggling with financial and data challenges in disaster planning.

Grace Science, LLC announced today that it has received FDA clearance of its Investigational New Drug (IND) application for GS-100, an AAV9 gene replacement therapy for the treatment of NGLY1 Deficiency.

BostonGene and LegoChem Biosciences, Inc. announced a collaboration to support the Phase I/II study of LCB84, a TROP2-directed ADC, in patients with advanced cancers.

MAIA Biotechnology, Inc. today reported financial results for the third quarter ended September 30, 2023 and key operational updates.

BioArctic AB’s partner Eisai held a presentation on the second quarter of Eisai’s fiscal year, ending March 2024.

At this year’s Radiological Society of North America’s annual meeting, international medical imaging IT and cybersecurity company Sectra will showcase its latest developments to make workflows even more efficient, regardless of reading location.